CASEY OWINGS: Open Payments
NPI 1609102201 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
| Lilly USA, LLC | 1 | $123 |
Products named: PENMENVY, Ozempic, XIFAXAN, JARDIANCE.
Industry payments across WA — which companies pay providers there.
